There is more than bottom line. You are saying that is OK to squander 400K plus on Lias because we squandered two million on the old BOD.Lias is not earning his obscene salary like the old BOD didn't earn theirs.John from Ronin talked about all of the long hanging fruit ready to be picked by AVID. Where is it? Enough time has passed.
Besides, Lias sounded like King on the last conference call and said in the ASM that nobody was interested in the IP only to find out that it is being used in a new phase II trial with additional trials being planned by Oncologie and their partner(s).Was that a lie? This is straight out of oncologie.com. You should visit it sometime.
And what did we get for a phase II drug? Eight million. Phase II drugs fetch billions. I know about the milestone payments and the royalties but how much of that will you get when and if AVID is swallowed by a bigger fish? Does nothing sounds like a good answer?
And since nobody was interested in the IP according to Lias how does it end up being bought by a private and new company and then end up in a phase II trial with more to come? Somebody must have said let's create a new company and buy Bavi beacuase it's not worth anything.
News 
Market Data 
Discover 
